Introduction
Materials and methods
Establishment of tumor xenografts
Histology and immunohistochemistry
Array comparative genomic hybridization
RNA extraction
Gene expression analysis
Affymetrix HGU133 Plus 2.0
Statistical analysis
Quality control analysis
Molecular subtype classification
Differential expression analysis
Gene ontology analysis
Results
Histologic and immunohistochemical analysis of tumors
Tumor xenograft | Phenotype (IHC) Patient/xenograft | Histology | Pearson's correlation coefficient |
---|---|---|---|
HBCx-3
| ER+/ER+ | IDC | 0.76 |
HBCx-5
| HER2+/HER2+ | IDC | 0.35 |
HBCx-6
| TN/TN | IDC | 0.60 |
HBCx-7
| TN/TN | ILC | 0.23 |
HBCx-8
| TN/TN | IDC | 0.82 |
HBCx-10
| TN/TN | IDC | 0.57 |
HBCx-11
| TN/TN | IDC | 0.65 |
HBCx-12A
| TN/TN | IDC | 0.66 |
HBCx-13A
| HER2+/HER2+ | IDC | 0.86 |
HBCx-15
| TN/TN | IDC | 0.57 |
HBCx-16
| TN/TN | IDC | 0.46 |
HBCx-17
| TN/TN | IDC | 0.39 |
HBCx-20
| ER+/ER+ | IDC | 0.87 |
HBCx-21
| ER+PR+/ER+PR+ | IDC | 0.86 |
HBCx-22
| ER+ PR+/ER+PR+ | IDC | 0.68 |
HBCx-23
| TN/TN | IDC | 0.80 |
HBCx-24
| TN/TN | IDC | 0.77 |
HBCx-31
| TN/TN | IDC | 0.86 |
Array CGH analysis of xenografts and corresponding patient tumors
Clustering of aCGH data set
Analysis of recurrent alterations observed in patient tumors and xenografts
Gain | Loss |
---|---|
1p22-36 | 1p12-36 |
2p16 | 1q21-q34 |
2p21-p24 | 2p11-q11 |
5p15 | 4p16 |
7q22 | 5q11-q31 |
9q34 | 9p23-24 |
10p15 | 9q13-32 |
11p13 | 11p15 |
11q12-q14 | 11q22 |
13q13 | 12p11-p13 |
13q33-q34 | 12q21 |
14q11 | 15q24-q26 |
15q22-q25 | 16p13 |
16p13 | 17p11-13 |
17p11-q11 | 17q23-q24 |
18p11 | 18p11 |
19q13 | 18q12-q22 |
20q11 | 19p11-p12 |
22q12-q13 | 19q22 |
Molecular subtype classification
Tumor code | Origin | Molecular subtype |
---|---|---|
HBC(x)-3
| patient | LumA |
xenograft p2 | LumB | |
xenograft p6 | LumA | |
HBC(x)-5
| patient | LumA |
xenograft p2 | LumB | |
xenograft p5 | LumB | |
HBC(x)-6
| patient | Basal |
xenograft p0 | Basal | |
xenograft p6 | Unclassified | |
HBC(x)-7
| patient | Unclassified |
xenograft p7 | Unclassified | |
xenograft p9 | Unclassified | |
HBC(x)-10
| xenograft p4 | Basal |
xenograft p8 | Basal | |
patient | Basal | |
HBC(x)-13
| patient | LumA |
xenograft p6 | Unclassified | |
HBC(x)-15
| patient | Normal |
xenograft p1 | Basal | |
xenograft p5 | Basal | |
HBC(x)-12A
| patient (primary tumor) | Normal |
xenograft (primary) p8 | Unclassified | |
xenograft (primary) p5 | Basal | |
HBC(x)-12B
| patient (metastasis) | Unclassified |
xenograft (meta) p3 | Basal | |
xenograft (meta) p6 | Basal | |
HBC(x)-19
| patient | LumA |
xenograft | LumA |
Gene expression analysis
Gene Ontology Biologic Process | Count | % | List Total | Fold Enrichment | Benjamini |
---|---|---|---|---|---|
immune response | 98 | 16.2 | 479 | 4.01 | 8.12E-30 |
cell adhesion | 94 | 15.6 | 479 | 3.79 | 9.26E-27 |
biologic adhesion | 94 | 15.6 | 479 | 3.79 | 6.90E-27 |
response to wounding | 80 | 13.2 | 479 | 4.26 | 7.08E-26 |
defense response | 72 | 11.9 | 479 | 3.31 | 1.51E-16 |
inflammatory response | 49 | 8.1 | 479 | 4.26 | 7.35E-15 |
blood vessel development | 41 | 6.8 | 479 | 4.73 | 1.62E-13 |
vasculature development | 41 | 6.8 | 479 | 4.61 | 2.48E-13 |
extracellular matrix organization | 26 | 4.3 | 479 | 7.06 | 4.28E-12 |
positive regulation of immune system process | 35 | 5.8 | 479 | 4.15 | 8.12E-10 |
extracellular structure organization | 28 | 4.6 | 479 | 4.85 | 4.15E-09 |
wound healing | 30 | 5.0 | 479 | 4.44 | 6.13E-09 |
blood vessel morphogenesis | 31 | 5.1 | 479 | 4.15 | 1.38E-08 |
positive regulation of response to stimuli | 32 | 5.3 | 479 | 3.83 | 4.73E-08 |
regulation of response to external stimulus | 26 | 4.3 | 479 | 4.62 | 5.46E-08 |
taxis | 26 | 4.3 | 479 | 4.59 | 5.87E-08 |
chemotaxis | 26 | 4.3 | 479 | 4.59 | 5.87E-08 |
angiogenesis | 25 | 4.1 | 479 | 4.77 | 5.70E-08 |
regulation of cell activation | 27 | 4.5 | 479 | 4.36 | 7.17E-08 |
regulation of cell migration | 26 | 4.3 | 479 | 4.34 | 1.61E-07 |
skeletal system development | 36 | 6.0 | 479 | 3.19 | 3.25E-07 |
regulation of locomotion | 27 | 4.5 | 479 | 3.97 | 4.70E-07 |
regulation of cell motion | 27 | 4.5 | 479 | 3.95 | 5.01E-07 |
regulation of T cell activation | 21 | 3.5 | 479 | 5.07 | 4.87E-07 |